Watchman Heart Device: Marketing Outpaced Science?
Watchman Heart Device: Marketing Outpaced Science?
Watchman Heart Device: Marketing Outpaced Science?
Key points
اہم نکات
मुख्य बातें
- More than 600,000 patients worldwide have received Boston Scientific's Watchman heart implant, yet critics say the evidence that it prevents strokes as well as blood thinners is weak.
- The quarter-sized device is implanted in the heart to block clots in atrial fibrillation, and its advertising promises an easy way off blood-thinning drugs.
- A recent US safety alert linked the implant procedure to 120 serious injuries and 17 deaths, mostly from air entering the bloodstream.
- More than 600,000 patients worldwide have received Boston Scientific's Watchman heart implant, yet critics say the evidence that it prevents strokes as well as blood thinners is weak.
- The quarter-sized device is implanted in the heart to block clots in atrial fibrillation, and its advertising promises an easy way off blood-thinning drugs.
- A recent US safety alert linked the implant procedure to 120 serious injuries and 17 deaths, mostly from air entering the bloodstream.
- More than 600,000 patients worldwide have received Boston Scientific's Watchman heart implant, yet critics say the evidence that it prevents strokes as well as blood thinners is weak.
- The quarter-sized device is implanted in the heart to block clots in atrial fibrillation, and its advertising promises an easy way off blood-thinning drugs.
- A recent US safety alert linked the implant procedure to 120 serious injuries and 17 deaths, mostly from air entering the bloodstream.
More than 600,000 patients worldwide have received Boston Scientific's Watchman heart implant, yet critics say the evidence that it prevents strokes as well as blood thinners is weak. The quarter-sized device is implanted in the heart to block clots in atrial fibrillation, and its advertising promises an easy way off blood-thinning drugs. A recent US safety alert linked the implant procedure to 120 serious injuries and 17 deaths, mostly from air entering the bloodstream. Doctors who question the device say its trials were measured against older warfarin, not modern blood thinners, and that marketing has run ahead of the science.
More than 600,000 patients worldwide have received Boston Scientific's Watchman heart implant, yet critics say the evidence that it prevents strokes as well as blood thinners is weak. The quarter-sized device is implanted in the heart to block clots in atrial fibrillation, and its advertising promises an easy way off blood-thinning drugs. A recent US safety alert linked the implant procedure to 120 serious injuries and 17 deaths, mostly from air entering the bloodstream. Doctors who question the device say its trials were measured against older warfarin, not modern blood thinners, and that marketing has run ahead of the science.
More than 600,000 patients worldwide have received Boston Scientific's Watchman heart implant, yet critics say the evidence that it prevents strokes as well as blood thinners is weak. The quarter-sized device is implanted in the heart to block clots in atrial fibrillation, and its advertising promises an easy way off blood-thinning drugs. A recent US safety alert linked the implant procedure to 120 serious injuries and 17 deaths, mostly from air entering the bloodstream. Doctors who question the device say its trials were measured against older warfarin, not modern blood thinners, and that marketing has run ahead of the science.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।